Observational studyToxins2026

Effectiveness of Onabotulinumtoxin-A in Patients with Chronic Migraine and Previous CGRP-mAb Treatment Failure: A Multicentre 6-Month Real-World Experience.

Marcello Silvestro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.